Beta Drugs Limited (NSE:BETA)
India · Delayed Price · Currency is INR 1,670.20
-69.85 (-4.01%)
At close: Nov 7, 2025
Beta Drugs Market Cap
Beta Drugs has a market cap or net worth of 17.06 billion as of November 10, 2025. Its market cap has decreased by -1.80% in one year.
Market Cap
17.06B
Enterprise Value
17.29B
Revenue
3.90B
Ranking
n/a
PE Ratio
31.51
Stock Price
1,670.20
Market Cap Chart
Since October 25, 2017, Beta Drugs's market cap has increased from 915.98M to 17.06B, an increase of 1,762.46%. That is a compound annual growth rate of 43.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2025 | 17.06B | -11.67% |
| Dec 31, 2024 | 19.31B | 36.67% |
| Dec 29, 2023 | 14.13B | 107.04% |
| Dec 30, 2022 | 6.83B | 10.89% |
| Dec 31, 2021 | 6.16B | 497.76% |
| Dec 31, 2020 | 1.03B | 56.85% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reliance Industries | 20.15T |
| HDFC Bank | 15.13T |
| Bharti Airtel | 12.11T |
| Tata Consultancy Services | 10.82T |
| ICICI Bank | 9.63T |
| State Bank of India | 8.78T |
| Bajaj Finance | 6.74T |
| Infosys | 6.12T |